TY - JOUR T1 - An outbreak report of the two autochthonous cases of airport malaria in Belgium in 2020 JF - medRxiv DO - 10.1101/2021.09.29.21263834 SP - 2021.09.29.21263834 AU - Wim Van Bortel AU - Bea Van den Poel AU - Greet Hermans AU - Marleen Vanden Driessche AU - David Lerouge AU - Isra Deblauwe AU - Katrien De Wolf AU - Anna Schneider AU - Nick Van Hul AU - Ruth Müller AU - Leen Wilmaerts AU - Sophie Gombeer AU - Nathalie Smitz AU - Johanna Helena Kattenberg AU - Pieter Monsieurs AU - Anna Rosanas-Urgell AU - Marjan Van Esbroeck AU - Emmanuel Bottieau AU - Ula Maniewski-Kelner AU - Javiera Rebolledo Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/10/02/2021.09.29.21263834.abstract N2 - We report an outbreak investigation of two fatal cases of autochthonous Plasmodium falciparum that occurred in Belgium in September 2020. Various hypotheses of potential source of infection were investigated. Based on the collected information, the most likely route of transmission was through an infectious exotic Anopheles mosquito that arrived via the international airport of Brussels or the Military airport Melsbroek and infected the cases who lived at five kilometres from the airports. Based on a genomic analysis of the parasites collected from the two cases, the most likely origin of the Plasmodium was Gabon or Cameroon. Further, the parasites collected from the two Belgian patients were identical-by-descent, which supports the assumption that the two infections originated from the bite of the same mosquito, during an interrupted feeding. Despite these cases, airport malaria remains a rare event. Yet, it has significant implications, particularly for the patient, as delayed or missed diagnosis of the cause of illness often results in high rates of complications and mortality. Therefore, to prevent such severe or fatal outcomes, a number of public health actions are suggested including increased awareness among health practitioners especially those working in the vicinity of airports and increased surveillance of exotic mosquito species at airports.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Institute of Tropical Medicine implements exotic mosquito monitoring in Belgium through the projects The MEMO and MEMO+ project (from 2017 to 2020) which is funded by the Flemish, Walloon and Brussels regional governments and the Federal Public Service (FPS) Public Health, Food Chain Safety and Environment in the context of the National Environment and Health Action Plan (NEHAP) (Belgium). The entomological outbreak investigation was also financially supported by the Agentschap Zorg en Gezondheid. The Outbreak Research Team of the Institute of Tropical Medicine is financially supported by the Department of Economy, Science and Innovation of the Flemish government. The Barcoding Facility for Organisms and Tissues of Policy Concern (BopCo - http://bopco.myspecies.info/) is financed by the Belgian Science Policy Office (Belspo) as Belgian federal in-kind contribution to the European Research Infrastructure Consortium LifeWatch. The national reference laboratory of the Institute of Tropical Medicine is partially supported by The Federal Public Service Health, Food Chain Safety and Environment through a fund within the Health Insurance System. The genomic investigation was supported by Malariology Unit Funds to Rosanas-Urgell. The funders were not involved in the analysis nor the interpretation of the data.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This case report was notified to the Chairperson of the Institutional Review Board of the ITM on 17/06/2021. It was exempted from formal ethics approval, provided that consent was provided by the family members. We would like to thank the family members of the cases who facilitated the entomological investigations in the house and garden and who consented to this publicationAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is an outbreak investigation and all data are presented and available in the manuscript ER -